Solesta, an injectable gel delivered into the anal canal in an outpatient procedure, is a minimally invasive treatment option.
The FDA previously noted difficulties in treating fecal incontinence.
Related Articles on Incontinence:
FDA Approves Solesta to Treat Life-Altering Fecal Incontinence
FDA Gastroenterology and Urology Device Panel Approves Fecal Incontinence Product
USC Colorectal Surgeon Andreas Kaiser Named GI Journal Editor
